Stress and MDD effects on mPFC Glutamate and GABA during reward processing
Stress and MDD effects on mPFC Glutamate and GABA during reward processing
批准号:
8618562
负责人:
Michael Tilghman Treadway
金额:
$12.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-12-26 至 2015-11-30
关键词:
AddressAffectiveAgeAmino AcidsAminobutyric AcidsAnhedoniaAnimal ModelBehaviorBehavior assessmentBehavioral ModelBehavioral inhibitionBiological PsychiatryCause of DeathCorpus striatum structureDataDecision MakingDepressed moodDevelopmentEnvironmentEquilibriumEvaluationFunctional Magnetic Resonance ImagingFunctional disorderGenderGlutamatesGoalsHormonalHumanHydrocortisoneIndividualIndividual DifferencesLaboratoriesLearningLinkLiteratureMagnetic Resonance SpectroscopyMajor Depressive DisorderMeasuresMedialMediatingMediator of activation proteinMental disordersMentorsModelingMood DisordersMotivationMultimodal ImagingNeurotic DisordersNeurotransmittersOperant ConditioningParticipantPatient Self-ReportPatientsPerformancePhasePrefrontal CortexPreparationPrevalenceProcessProtonsPsychological reinforcementPsychosocial StressPunishmentReadingRelative (related person)ResearchRestRewardsRisk FactorsRoleSalivarySamplingScanningSchoolsSignal TransductionStressSupervisionSymptomsTechniquesTestingTrainingUnited StatesWorkacute stressbasebehavior measurementcognitive neurosciencedepressive symptomsdesigndisabilityin vivoinsightlearned behaviormeetingsneuroimagingneurotransmissionpublic health relevanceresponsereward processingskillssocialsocial stressstressortrait
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
With a lifetime prevalence of 16%, Major Depressive Disorder (MDD) is predicted to become the second
leading cause of death and disability in the United States by the year 2020. A core feature of MDD is reward-
processing deficits in the form of decreased reward motivation and anhedonia. These deficits have been
linked to alterations in corticostriatal networks in MDD, but less is known about the specific mechanisms that
may contribute to these changes. One candidate mechanism is alterations in medial prefrontal glutamate (Glu)
and GABA, both of which have recently been implicated in both MDD, as well as a key risk-factor for the
development of MDD, stress. To date however, no study has provided an in vivo assessment of Glu and GABA
function in response to psychosocial stress in MDD or in healthy controls. To address this question, the K99
phase of this application proposes the following training goals. First, in order to develop the technical skills
needed to assess Glu and GABA in vivo, the candidate will learn MR-Spectroscopy techniques from Dr. J. Eric
Jensen (K99 Co-mentor) and Dr. Dost Ong¿r (Consultant). This will involve the completion of a combined
MRS/fMRI study that will explore the relationships between baseline Glu and GABA function and BOLD fMRI
signals during reinforcement learning in healthy participants. Second, the candidate will deepen his
understanding of the role of Glu and GABA function in reward processing through directed readings with Dr.
Kent Berridge (Consultant) as well as their relevance to the pathophysiology of mood disorders through
readings supervised by Dr. Ong¿r. Third, he will build upon his behavioral modeling skills developed in
graduate school through the application of a reinforcement learning paradigm and associated Q-learning model
analysis, which will be supervised by Dr. Michael Frank (Consultant); the candidate will also attend Dr. Frank's
lab meetings on a monthly basis as well as his course "Computational Cognitive Neuroscience". Finally, the
candidate will receive guidance and supervision from his primary mentor, Dr. Diego Pizzagalli, in the
integration multimodal imaging data, design and analysis of laboratory stressors, and preparation towards the
development of an independent laboratory. During the independent phase, two additional multimodal imaging
studies are proposed that will combine MRS assessment of Glu and GABA function with fMRI measures of
reinforcement learning both before and after a psycho-social stressor. The first of these studies will be focused
on healthy controls, while the second will include a sample of patients with MDD and matched controls.
Through its use of multimodal imaging focused on two major neurotransmitters, a pre-post stress manipulation
and inclusion of both controls and MDD patients, the proposed research will provide important new insights
into the role of Glu and GABA function in the pathophysiology of reward processing deficits in MDD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine
-
批准号:10375849
-
项目类别:
-
资助金额:$77.88万
-
财政年份:2022
-
负责人:Michael Tilghman Treadway
-
依托单位:
Glutamatergic adaptation to stress as a mechanism for anhedonia and treatment response with ketamine
-
批准号:10571930
-
项目类别:
-
资助金额:$76.23万
-
财政年份:2022
-
负责人:Michael Tilghman Treadway
-
依托单位:
Transdiagnostic and Disorder-Specific Effects of Immune and Metabolic Factors on Motivational Deficits Across Mood and Psychotic Disorders
-
批准号:9979349
-
项目类别:
-
资助金额:$42.9万
-
财政年份:2020
-
负责人:Michael Tilghman Treadway
-
依托单位:
Dynamics of Inflammation and its Blockade on Motivational Circuitry in Depression
-
批准号:9318578
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2016
-
负责人:Michael Tilghman Treadway
-
依托单位:
Dynamics of Inflammation and its Blockade on Motivational Circuitry in Depression
-
批准号:9917858
-
项目类别:
-
资助金额:$41.4万
-
财政年份:2016
-
负责人:Michael Tilghman Treadway
-
依托单位:
Stress and MDD effects on mPFC Glutamate and GABA during reward processing
-
批准号:8994068
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2015
-
负责人:Michael Tilghman Treadway
-
依托单位:
Stress and MDD effects on mPFC Glutamate and GABA during reward processing
-
批准号:9212197
-
项目类别:
-
资助金额:$24.23万
-
财政年份:2015
-
负责人:Michael Tilghman Treadway
-
依托单位:
Stress and MDD effects on mPFC Glutamate and GABA during reward processing
-
批准号:8788444
-
项目类别:
-
资助金额:$3.23万
-
财政年份:2013
-
负责人:Michael Tilghman Treadway
-
依托单位:
Neural Mechanisms of Effort-Based Reward in Humans
-
批准号:7886565
-
项目类别:
-
资助金额:$2.25万
-
财政年份:2009
-
负责人:Michael Tilghman Treadway
-
依托单位:
海外基金